Effect of cardiovascular drug classes on all-cause mortality among atrial fibrillation patients treated in primary care in Sweden: a cohort study.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 22990327)

Published in Eur J Clin Pharmacol on September 19, 2012

Authors

Per Wändell1, Axel C Carlsson, Kristina Sundquist, Sven-Erik Johansson, Jan Sundquist

Author Affiliations

1: Centre for Family Medicine, Karolinska Institutet, Alfred Nobels Allé 12, 141 83 Huddinge, Sweden. per.wandell@ki.se

Articles cited by this

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA (2002) 36.26

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93

Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med (2007) 10.87

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med (1995) 7.83

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76

Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation (2006) 3.69

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace (2006) 3.52

Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up. J Hypertens (2007) 1.96

Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Eur Heart J (2006) 1.91

New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation (2001) 1.83

Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol (2004) 1.77

Confounding and indication for treatment in evaluation of drug treatment for hypertension. BMJ (1997) 1.34

Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev (2007) 1.33

Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients? Am J Med (2010) 1.24

Aldosterone: role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome. Clin J Am Soc Nephrol (2010) 1.11

Coronary heart disease risks in first- and second-generation immigrants in Sweden: a follow-up study. J Intern Med (2006) 1.11

Country of birth, socioeconomic factors, and risk factor control in patients with type 2 diabetes: a Swedish study from 25 primary health-care centres. Diabetes Metab Res Rev (2011) 1.08

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev (2012) 1.07

Treatment of atrial fibrillation. Br Med Bull (2008) 1.04

Survival after stroke--the impact of CHADS2 score and atrial fibrillation. Int J Cardiol (2009) 1.01

Gender in atrial fibrillation: Ten years later. Gend Med (2010) 1.00

Atrial fibrillation in congestive heart failure. Cardiol Rev (2009) 0.95

The influence of gender on the effects of aspirin in preventing myocardial infarction. BMC Med (2007) 0.92

Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors' adherence to warfarin therapy recommendations: a Swedish study of prescribed drugs in primary care in 2002 and 2007. Eur J Clin Pharmacol (2012) 0.92

The role of 'confounding by indication' in assessing the effect of quality of care on disease outcomes in general practice: results of a case-control study. BMC Health Serv Res (2005) 0.90

Drug prescription in men and women with type-2 diabetes in Stockholm in 1995 and 2001: change over time. Eur J Clin Pharmacol (2002) 0.86

A survey of subjects with present or previous atrial fibrillation in a Swedish community. Scand J Prim Health Care (2001) 0.86

Digoxin for the treatment of chronic and acute heart failure syndromes. Acute Card Care (2009) 0.85

Digitalis for treatment of congestive heart failure in patients in sinus rhythm: a systematic review and meta-analysis. J Card Fail (2004) 0.84

Metabolic control and quality of data in medical records for subjects with type 2 diabetes in Swedish primary care: improvement between 1995 and 2001. Scand J Prim Health Care (2002) 0.83

Cholesterol and cardiac arrhythmias. Expert Rev Cardiovasc Ther (2010) 0.83

Cardiovascular and total mortality in men and women with different blood pressure levels--A 26-year follow-up. Blood Press (2009) 0.80

Five-year mortality in men and women with atrial fibrillation. Scand J Prim Health Care (2001) 0.80

Total mortality among levothyroxine-treated women with atrial fibrillation in Swedish primary health care. Int J Cardiol (2011) 0.80

Lipid-altering therapy and atrial fibrillation. Cardiol Rev (2008) 0.79

Influence of gender on long-term prognosis of patients with chronic heart failure seen in heart failure clinics. Clin Cardiol (2010) 0.78

Atrial fibrillation and mortality: the impact of antithrombotic therapy. Eur Heart J (2010) 0.77

Atherothrombotic disease and the role of antiplatelet therapy in women. J Womens Health (Larchmt) (2008) 0.75

Articles by these authors

Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology (2005) 5.77

Urbanisation and incidence of psychosis and depression: follow-up study of 4.4 million women and men in Sweden. Br J Psychiatry (2004) 4.94

Gestational age at birth and mortality in young adulthood. JAMA (2011) 3.31

Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community. Kidney Int (2012) 2.61

Identification of population subgroups of children and adolescents with high asthma prevalence: findings from the Third National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med (2002) 2.38

Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden. Lancet Oncol (2012) 2.32

Site-specific survival rates for cancer of unknown primary according to location of metastases. Int J Cancer (2013) 2.24

Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology (2009) 2.19

Mental disorders and vulnerability to homicidal death: Swedish nationwide cohort study. BMJ (2013) 2.16

Inequities in CHD incidence and case fatality by neighborhood deprivation. Am J Prev Med (2007) 2.16

High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol (2005) 2.13

Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet (2011) 2.12

Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics (2008) 2.11

Familial renal cell carcinoma from the Swedish Family-Cancer Database. Eur Urol (2011) 2.10

IQ and schizophrenia in a Swedish national sample: their causal relationship and the interaction of IQ with genetic risk. Am J Psychiatry (2014) 2.05

Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry (2013) 2.03

Neighborhood socioeconomic environment and incidence of coronary heart disease: a follow-up study of 25,319 women and men in Sweden. Am J Epidemiol (2004) 2.01

Genetic and familial environmental influences on the risk for drug abuse: a national Swedish adoption study. Arch Gen Psychiatry (2012) 2.00

Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol (2009) 1.95

Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut (2006) 1.92

Neighborhood deprivation and cardiovascular disease risk factors: protective and harmful effects. Scand J Public Health (2006) 1.85

Increased risks of coronary heart disease and stroke among spousal caregivers of cancer patients. Circulation (2012) 1.82

Genetic and family and community environmental effects on drug abuse in adolescence: a Swedish national twin and sibling study. Am J Psychiatry (2014) 1.82

Do immigrants have an increased prevalence of unhealthy behaviours and risk factors for coronary heart disease? Eur J Cardiovasc Prev Rehabil (2005) 1.79

Risk of cancer following hospitalization for type 2 diabetes. Oncologist (2010) 1.75

Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden. Circulation (2011) 1.73

Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum (2009) 1.73

The validity of questionnaire-based micronutrient intake estimates is increased by including dietary supplement use in Swedish men. J Nutr (2004) 1.66

Neighborhood violent crime and unemployment increase the risk of coronary heart disease: a multilevel study in an urban setting. Soc Sci Med (2005) 1.65

Low-linking social capital as a predictor of mental disorders: a cohort study of 4.5 million Swedes. Soc Sci Med (2006) 1.50

Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden. Thromb Haemost (2013) 1.50

Preterm birth and risk of medically treated hypothyroidism in young adulthood. Clin Endocrinol (Oxf) (2011) 1.48

Gestational age at birth and risk of testicular cancer. Int J Cancer (2011) 1.45

Shared familial aggregation of susceptibility to autoimmune diseases. Arthritis Rheum (2009) 1.45

Psychiatric comorbidities in patients with hypertension - a study of registered diagnoses 2009-2013 in the total population in Stockholm County, Sweden. J Hypertens (2016) 1.42

Low linking social capital as a predictor of coronary heart disease in Sweden: a cohort study of 2.8 million people. Soc Sci Med (2005) 1.42

The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies. Int J Cancer (2010) 1.42

Breast cancer risk in women who fulfill high-risk criteria: at what age should surveillance start? Breast Cancer Res Treat (2009) 1.42

Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry (2013) 1.40

Effect of cardiovascular drugs on mortality in atrial fibrillation and chronic heart failure. Scand Cardiovasc J (2014) 1.40

Ethnicity, acculturation, and self reported health. A population based study among immigrants from Poland, Turkey, and Iran in Sweden. J Epidemiol Community Health (2004) 1.39

Mortality causes in cancer patients with type 2 diabetes mellitus. Eur J Cancer Prev (2012) 1.39

Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes. BMC Cancer (2010) 1.30

Physical activity, exercise and self-rated health: a population-based study from Sweden. BMC Public Health (2008) 1.26

Increasing CSF phospho-tau levels during cognitive decline and progression to dementia. Neurobiol Aging (2007) 1.21

Within-family environmental transmission of drug abuse: a Swedish national study. JAMA Psychiatry (2013) 1.20

Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol (2010) 1.18

Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden. Schizophr Bull (2012) 1.18

Risk of hypertension among young adults who were born preterm: a Swedish national study of 636,000 births. Am J Epidemiol (2011) 1.18

Women, international migration and self-reported health. A population-based study of women of reproductive age. Soc Sci Med (2003) 1.15

The long-term effect of physical activity on incidence of coronary heart disease: a 12-year follow-up study. Prev Med (2004) 1.15

Cancer risks in ulcerative colitis patients. Int J Cancer (2008) 1.15

Risk of asthma in young adults who were born preterm: a Swedish national cohort study. Pediatrics (2011) 1.14

The influences of place of birth and socioeconomic factors on attempted suicide in a defined population of 4.5 million people. Arch Gen Psychiatry (2003) 1.13

Physical activity and concordance between objective and perceived walkability. Med Sci Sports Exerc (2012) 1.12

Familial risks for type 2 diabetes in Sweden. Diabetes Care (2009) 1.10

Neighborhood deprivation and psychiatric medication prescription: a Swedish national multilevel study. Ann Epidemiol (2011) 1.10

Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology. Clin J Am Soc Nephrol (2013) 1.10

Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer (2012) 1.09

Incidence trends of squamous cell and rare skin cancers in the Swedish national cancer registry point to calendar year and age-dependent increases. J Invest Dermatol (2010) 1.09